Perceptions of COVID-19 vaccination in patients with genitourinary cancers: a survey study.
Cancer Invest
; : 1-9, 2022 Oct 14.
Article
in English
| MEDLINE | ID: covidwho-2228631
ABSTRACT
Since the approval of the COVID-19 vaccines, their safety and efficacy has been widely demonstrated in patients with cancer.â¯However, there remain patients with reservations regarding vaccination. We aimed to assess genitourinary cancer patients' perceptions of the vaccines as well as barriers and influencers of decision-making through the completion of a questionnaire. While vaccine-associated concerns were observed, most patients with genitourinary cancers were willing to receive the vaccine. Moving forward, differing strategies could be considered to enhance patient education on the utility of vaccination in the setting of cancer and beyond.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Observational study
Topics:
Vaccines
Language:
English
Journal:
Cancer Invest
Year:
2022
Document Type:
Article
Affiliation country:
07357907.2022.2136683
Similar
MEDLINE
...
LILACS
LIS